| アイテムタイプ |
学術雑誌掲載論文(1) |
| 公開日 |
2026-02-05 |
| タイトル |
|
|
タイトル |
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 著者 |
Kotani Daisuke
Yoshino Takayuki
Masuishi Toshiki
Sunakawa Yu
Takashima Atsuo
Yamazaki Kentaro
Kawakami Hisato
Nishina Tomohiro
Komatsu Yoshito
Esaki Taito
Eng Cathy
Ukrainskyj Stacey
Pallai Rajash
Nanda Shivani
Yang Zhao
Schelman William
Kania Marek
Satoh Taroh
|
| キーワード |
|
|
言語 |
en |
|
主題 |
Fruquintinib, Japan subgroup analysis, Metastatic colorectal cancer, VEGFR inhibitor |
| 識別子 |
|
|
識別子 |
https://doi.org/10.1007/s10147-025-02852-9 |
|
識別子タイプ |
DOI |
| 書誌情報 |
en : International journal of clinical oncology
巻 30,
号 10,
p. 2043-2052,
ページ数 10,
発行日 2025-09-01
|
| 出版者 |
|
|
出版者 |
Springer Nature |
|
言語 |
en |
| 収録物識別子 |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1437-7772 |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| アクセス権 |
|
|
アクセス権 |
open access |
| 権利情報 |
|
|
権利情報 |
© The Author(s) 2025 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
s10147-025-02852-9.pdf (557 KB)
.png)
10147_2025_2852_MOESM1_ESM.docx (35 KB)
